SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-013451
Filing Date
2021-02-23
Accepted
2021-02-23 19:12:39
Documents
2
Period of Report
2021-02-19

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2170
2 POA DOCUMENT poa.txt EX-24.3_965860 4237
  Complete submission text file 0001209191-21-013451.txt   7899
Mailing Address 800 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address 800 SAGINAW DRIVE REDWOOD CITY CA 94063 650-272-6269
Adverum Biotechnologies, Inc. (Issuer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O UNITEDHEALTH GROUP INCORPORATED 9900 BREN ROAD EAST MINNETONKA MN 55123
Business Address
Tuckson Reed Vaughn (Reporting) CIK: 0001511051 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36579 | Film No.: 21667744